Fig. 2: Time from randomisation to best confirmed response in responders (n = 13). | Blood Cancer Journal

Fig. 2: Time from randomisation to best confirmed response in responders (n = 13).

From: Single-agent belantamab mafodotin for relapsed/refractory multiple myeloma: analysis of the lyophilised presentation cohort from the pivotal DREAMM-2 study

Fig. 2

Abbreviations: PR partial response, VGPR very good partial response. Responses were assessed by an independent review committee according to International Myeloma Working Group criteria20. Orange triangles represent patients with study treatment ongoing. Asterisks represent patients with follow-up ongoing. Responses are indicated at the time of the first report of ≥PR, followed by best response, unless the two occurred concurrently.

Back to article page